Fennec Pharmaceuticals, Inc. (FENC)
8.00
+0.20
(+2.56%)
USD |
NASDAQ |
Mar 17, 11:28
Fennec Pharmaceuticals Shareholders Equity (Quarterly) : -4.492M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 86.48B |
| REGENXBIO, Inc. | 102.73M |
| Zymeworks, Inc. | 268.50M |
| Apellis Pharmaceuticals, Inc. | 370.15M |
| Gossamer Bio, Inc. | -82.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 49.26M |
| Total Liabilities (Quarterly) | 53.75M |
| Debt to Equity Ratio | -4.031 |
| Current Ratio | 4.693 |
| Net Debt Paydown Yield | 0.89% |